Evicenter
MarkdownMedical informationP&T meetings
Onvuzosiran (ADX-324)

Prophylaxis of hereditary angioedema attacks

Launch
Not announced
Last updated
119 sources

Product information and disease descriptionProduct description

Product information

65 evidence topics · 31 sources

Average sales price and wholesale acquisition cost

Not applicable.

Contraindications/Warnings/Precautions/Adverse effects
Warnings and precautions

Not applicable.

Drug/Drug, drug/disease interactions
Effects of other drugs on Onvuzosiran

No evidence found.

Effects of Onvuzosiran on other drugs

No evidence found.

Effect of Onvuzosiran on quality measures

No evidence found.